BioInvent International AB (BOVNF)
3.289
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
BioInvent International Total Liabilities (Quarterly) : 10.06M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 10.06M |
| December 31, 2025 | 12.32M |
| September 30, 2025 | 10.93M |
| June 30, 2025 | 11.11M |
| March 31, 2025 | 9.265M |
| December 31, 2024 | 9.36M |
| September 30, 2024 | 8.324M |
| June 30, 2024 | 9.582M |
| March 31, 2024 | 8.977M |
| December 31, 2023 | 8.975M |
| September 30, 2023 | 7.067M |
| June 30, 2023 | 11.33M |
| March 31, 2023 | 8.931M |
| December 31, 2022 | 10.18M |
| September 30, 2022 | 6.384M |
| June 30, 2022 | 8.721M |
| March 31, 2022 | 8.741M |
| December 31, 2021 | 8.872M |
| September 30, 2021 | 8.537M |
| June 30, 2021 | 9.364M |
| March 31, 2021 | 7.032M |
| December 31, 2020 | 7.201M |
| September 30, 2020 | 5.557M |
| June 30, 2020 | 6.161M |
| March 31, 2020 | 5.842M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.054M |
| September 30, 2019 | 6.442M |
| June 30, 2019 | 7.471M |
| March 31, 2019 | 5.540M |
| December 31, 2018 | 3.697M |
| September 30, 2018 | 2.749M |
| June 30, 2018 | 4.698M |
| March 31, 2018 | 4.884M |
| December 31, 2017 | 4.864M |
| September 30, 2017 | 3.741M |
| June 30, 2017 | 4.220M |
| March 31, 2017 | 3.394M |
| December 31, 2016 | 5.048M |
| September 30, 2016 | 3.865M |
| June 30, 2016 | 3.578M |
| March 31, 2016 | 3.497M |
| December 31, 2015 | 2.965M |
| September 30, 2015 | 2.229M |
| June 30, 2015 | 2.199M |
| March 31, 2015 | 2.164M |
| December 31, 2014 | 2.770M |
| September 30, 2014 | 2.767M |
| June 30, 2014 | 4.202M |
| March 31, 2014 | 3.721M |
| December 31, 2013 | 5.049M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BONESUPPORT HOLDING AB | 18.89M |
| Hansa Biopharma AB | 150.89M |
| BioArctic AB | 50.51M |
| Swedish Orphan Biovitrum AB | 4.291B |
| Diamyd Medical AB | 9.292M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.16M |
| Shareholders Equity (Quarterly) | 46.09M |
| Debt to Equity Ratio | 0.0142 |
| Current Ratio | 5.316 |
| Net Debt Paydown Yield | 0.08% |